FigureĀ 2.
Ranked distributions of variant abundance and maximum VAF based on final diagnosis. (Top) Ranked distribution of the percentage of patients with variants reported based on the final diagnosis in 53 reviewed genes with any detected variants. (Bottom) Ranked distributions of variant abundance and maximum VAF by final diagnosis and gene: Ranked median maximum VAF distribution by final diagnosis in 53 reviewed genes with maximum VAFs >0. (Left) Myeloid vs no myeloid malignancy. (Right) MDS vs non-MDS myeloid malignancy.

Ranked distributions of variant abundance and maximum VAF based on final diagnosis. (Top) Ranked distribution of the percentage of patients with variants reported based on the final diagnosis in 53 reviewed genes with any detected variants. (Bottom) Ranked distributions of variant abundance and maximum VAF by final diagnosis and gene: Ranked median maximum VAF distribution by final diagnosis in 53 reviewed genes with maximum VAFs >0. (Left) Myeloid vs no myeloid malignancy. (Right) MDS vs non-MDS myeloid malignancy.

Close Modal

or Create an Account

Close Modal
Close Modal